RegeneRx Biopharmaceuticals, Inc.

OTCPK:RGRX Stock Report

Market Cap: US$2.1k

RegeneRx Biopharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RGRX?
Owner TypeNumber of SharesOwnership Percentage
Institutions00%
Individual Insiders99,9956.63%
Public Companies195,83313%
Private Companies364,89124.2%
General Public847,87256.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.1%.


Top Shareholders

Top 7 shareholders own 43.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.2%
Alfasigma S.p.A.
349,891US$489.80%no data
13%
HLB Therapeutics Co.,Ltd.
195,833US$274.20%no data
4.32%
Joseph McNay
65,241US$91.30%no data
1.17%
J. Finkelstein
17,694US$24.80%no data
1.06%
Allan Goldstein
16,015US$22.40%no data
0.99%
Aptafin S.p.A.
15,000US$21.00%no data
0.069%
R. Elsey
1,045US$1.50%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.